Putnam Investments’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Putnam Investments’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,750	Closed	-$322K	–	1386
2016 Q2	$322K	Hold	3,750	–	–	﹤0.01%	1253
2016 Q1	$347K	Hold	3,750	–	–	﹤0.01%	1299
2015 Q4	$752K	Hold	3,750	–	–	﹤0.01%	1216
2015 Q3	$560K	Hold	3,750	–	–	﹤0.01%	1306
2015 Q2	$3.56M	Hold	3,750	–	–	0.01%	859
2015 Q1	$2.75M	Buy	+3,750	New	+$2.82M	0.01%	951

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Putnam Investments's TTPH Position: Q3 2016 in Review

Putnam Investments sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2016, closing a stake of 3,750 shares — an estimated $322K sold.

Putnam Investments first reported a position in TTPH in Q1 2015 and held it in 6 quarters. The position peaked at $3.56M in Q2 2015. 90 funds tracked by Wall St. Rank hold TTPH as of Q3 2016.

Putnam Investments reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
Putnam Investments sold 3,750 Tetraphase Pharmaceuticals, Inc. shares in Q3 2016, an estimated $322K.
Putnam Investments first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
Putnam Investments's Tetraphase Pharmaceuticals, Inc. position peaked at $3.56M in Q2 2015.
90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.